Skip to main content
Premium Trial:

Request an Annual Quote

Enpicom ImmunoGenomiX Platform With Antibody Discovery Mode

Netherlands-based Enpicom has released its ImmunoGenomiX (IGX) bioinformatics platform with an antibody discovery module. The IGX platform is designed to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. It is technology-agnostic and code-free, and enables scientists to securely analyze immune repertoires, the company said. The new antibody discovery module applications are IGX-Cluster and IGX-Branch. IGX-Cluster groups sequences based on user-defined parameters such as CDR3 similarity, gene usage, and CDR3 length. It performs large clustering tasks in the cloud and supports a wide variety of workflows for both paired and unpaired receptor chains. Subsequently, IGX-Branch creates interactive visualizations to prioritize clusters and pick antibody candidates for follow-up analysis through information-rich phylogenetic trees.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.